November 8, 2014
J Eur Acad Dermatol Venereol. 2013 Feb;27(2):133-41. doi: 10.1111/j.1468-3083.2012.04562.x. Epub 2012 May 8.
Author Address: Department of Dermatology, Venereology and Allergy, Charite – University Medicine, Berlin, Germany. firstname.lastname@example.org
Reference Type: Journal Article
Record Number: 4496Author: Maurice, P. D., Fenton, T., Cross, N., Thomson, I. A., Rennie, S. C. and van Rij, A. M.
Title: A dedicated dermatology clinic for renal transplant recipients: first 5 years of a New Zealand experience
Journal: N Z Med J
Date: Feb 15
Short Title: A dedicated dermatology clinic for renal transplant recipients: first 5 years of a New Zealand experience
Alternate Journal: The New Zealand medical journal
ISSN: 1175-8716 (Electronic)
Accession Number: 23463107
Keywords: Carcinoma, Basal Cell/diagnosis/*epidemiology
Carcinoma, Squamous Cell/diagnosis/*epidemiology
Dermatology/organization & administration
Kidney Transplantation/*adverse effects/statistics & numerical data
Postoperative Care/*methods/statistics & numerical data
Abstract: AIM: Cancer following organ transplantation is a growing public health concern. We describe the first 5 years’ experience of a dedicated dermatology clinic for renal transplant recipients, the first of its type in New Zealand. METHODS: Data from patients seen in the clinic were collected on a nephrology/dermatology database. RESULTS: 86 of 99 transplant recipients had a baseline dermatology assessment. Seventy-one skin cancers (45 squamous, 25 basal cell carcinomas, 1 melanoma) were found in 17 patients. Eighteen of these were an incidental finding at the baseline post-transplant examination of 7 patients: they had not been noted either by the patient or by their nephrologist. A further 44 cancers were found in 13 patients at follow-up examinations in the dedicated clinic. Squamous and basal cell carcinomas received definitive treatment after 26 and 38 days (median) respectively. A brief analysis showed this to be a cost-effective way of diagnosing and treating skin cancer in this cohort of patients. CONCLUSION: The clinic is enabling prompt diagnosis and cost-effective treatment of skin cancers developing in renal transplant recipients and is also identifying significant numbers of pre-existing skin cancers in these patients.